30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Bahija Jallal

Track

Insider profile

Currently holds positions in Medimmune LLC, Elevance Health Inc and Guardant Health Inc

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, Research & Development Medimmune LLC None -
Independent Director Elevance Health Inc Feb. 1, 2018 -
Independent Director Guardant Health Inc April 17, 2019 -
Executive Vice President, MedImmune AstraZeneca PLC Jan. 1, 2013 - Jan. 1, 2019
Bahija Jallal's trades of Immunocore Holdings PLC's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-19 2026-02-18
S Sale
63,063 +0.7%
36.72
US$40,840 		63,063 +0.7% 36.72 US$40,840
2026-02-18 2026-02-18
PrS Proposed sale
72,808
38.95
US$1,158,880 		72,808 38.95 US$1,158,880
2023-12-27 2023-12-27
PrS Proposed sale
50,693
104.86
US$2,505,721 		50,693 104.86 US$2,505,721
2023-07-12 2023-07-12
PrS Proposed sale
50,000
65.00
US$3,250,000 		50,000 65.00 US$3,250,000
2023-05-08 2023-05-08
PrS Proposed sale
50,000
60.00
US$3,000,000 		50,000 60.00 US$3,000,000
2023-04-17 2023-04-17
PrS Proposed sale
100,000
55.00
US$5,500,000 		100,000 55.00 US$5,500,000